Manufacturing, Gene Therapies

CGT Catapult Announces Expansion into Scotland

June 30, 2021

The Cell and Gene Therapy Catapult will establish offices and laboratories in Edinburgh, Scotland.

Genezen Invests in New CGMP Lentiviral Vector Production Facility

June 29, 2021

Genezen Laboratories has broken ground on a new current good manufacturing practice (CGMP)-compliant lentiviral vector production facility.

University of Birmingham Joins Advanced Therapies Skills Training Network

June 24, 2021

The University of Birmingham has been confirmed as the third National Training Centre in the Advanced Therapies Skills Training Network (ATSTN) initiative

Ilya Pharma Receives Approval from Swedish Regulators for Phase II Study

June 23, 2021

Ilya Pharma has been granted approval by the Swedish Medical Product Agency and Swedish Ethical Review Authority for initiation of a Phase II clinical trial of its ILP100 gene therapy.

Horiba Joins CGT Catapult Consortium to Accelerate Development of PAT

June 18, 2021

Horiba has joined a consortium aimed at accelerating the development of process analytical technologies for cell and gene therapy manufacturing

Yposkesi Launches Project SKY for its Second Commercial Bioproduction Site

June 16, 2021

Yposkesi is building its second commercial facility for cell and gene therapy manufacturing at its campus on Corbeil-Essonnes, France.

CGT Catapult Forms Consortium to Accelerate Manufacturing Technology Development

June 11, 2021

The CGT Catapult has formed a consortium aimed at advancing the technology development and lowering costs of cell and gene therapy manufacturing.

VIVEbiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapies

June 08, 2021

VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.

The Discovery Labs Secures Pennsylvania Location for New Life Sciences Cluster

May 27, 2021

The Discovery Labs has signed a foundational lease with the University of Pennsylvania Gene Therapy Program to build a new life sciences cluster in King of Prussia, Pa.

Biogen and Ginkgo Bioworks in $120-Million Deal to Develop Novel Gene Therapy Manufacturing Platform

May 27, 2021

Biogen and Ginkgo Bioworks have partnered to develop a next-generation AAV production platform to accelerate Biogen’s gene therapy drug development efforts.